CCDC13-AS1

Across TCGA pan-cancer cohorts, CCDC13-AS1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated CCDC13-AS1 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher CCDC13-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated CCDC13-AS1 expression acts as an unfavorable survival marker, although some lineages such as KIRP and MESO show a favorable association.

KIRP, KIRC, and KICH are the cancer types where CCDC13-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Median	All	0.966	0.851	<.001	135	view →
KIRC	OS	Tertile	All	0.565	0.740	<.001	118	view →
KICH	DFS	Median	II,III,IV	0.694	1.000	.002	94	view →
MESO	DFS	Quartile	All	0.574	0.270	.001	53	view →
SKCM	OS	Tertile	III,IV	0.905	0.762	.001	46	view →
BLCA	OS	Median	II,III,IV	0.553	0.341	.002	44	view →
LUAD	OS	Quartile	All	0.803	0.601	<.001	39	view →
PAAD	OS	Quartile	All	0.577	0.237	<.001	34	view →
STAD	OS	Median	All	0.439	0.319	.011	24	view →
LAML	DFS	Quartile	All	0.423	0.696	.008	20	view →
THYM	DFS	Tertile	II,III,IV	0.964	0.751	.007	19	view →
READ	OS	Median	II,III,IV	1.000	0.844	.006	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

CCDC13-AS1–KIRP (DFS)

Open the KIRP breakdown →